Secondary Logo

Institutional members access full text with Ovid®

Proinflammatory Cytokines, Mood, and Sleep in Interepisode Bipolar Disorder and Insomnia: A Pilot Study With Implications for Psychosocial Interventions

Dolsen, Michael, R., MA; Soehner, Adriane, M., PhD; Harvey, Allison, G., PhD

doi: 10.1097/PSY.0000000000000529
ORIGINAL ARTICLES
Buy
SDC

Objective Proinflammatory cytokines are associated with bipolar disorder (BD), but less is known about how cytokines function during the interepisode period. This study examined cytokines, mood symptoms, and sleep in individuals with interepisode BD with complaints of insomnia. We also investigated the effects of a BD-specific modification of cognitive behavior therapy for insomnia (CBTI-BP) on cytokine levels.

Methods Twenty-two adults with interepisode BD type I and insomnia were drawn from a subset of a National Institute of Mental Health funded study. Participants were randomly allocated to CBTI-BP (n = 11) or psychoeducation (n = 11). Participants completed a sleep diary, rated self-report measures of mania and depression, and provided samples assayed for interleukin (IL)-6 and tumor necrosis factor soluble receptor 2 (sTNF-R2).

Results IL-6 was associated with mania symptoms (r s = 0.44, p = .041) and total sleep time (r s = −0.49, p = .026). IL-6 was related to depression symptoms at the trend level (r s = 0.43, p = .052). sTNF-R2 was not significantly related to mood or sleep measures. From pretreatment to posttreatment, CBTI-BP compared with psychoeducation was associated with a nonsignificant, large effect size decrease in IL-6 (z = −1.61, p = .13, d = −0.78) and a nonsignificant, small-medium effect size decrease in sTNF-R2 (z = −0.79, p = .44, d = −0.38).

Conclusions These findings provide preliminary evidence that IL-6 is related to mania symptoms and shorter total sleep time in interepisode BD. A treatment that targets sleep in BD could potentially decrease IL-6 although replication is warranted.

From the Department of Psychology (Dolsen, Harvey), University of California, Berkeley; and Department of Psychiatry (Soehner), University of Pittsburgh School of Medicine, Pennsylvania.

Address correspondence and reprint requests to Allison G. Harvey, PhD, Department of Psychology, University of California, Berkeley, 2205 Tolman Hall #1650, Berkeley, CA 94720-1650. E-mail: aharvey@berkeley.edu

Supplemental Content

Received for publication January 6, 2017; revision received August 31, 2017.

Copyright © 2018 by American Psychosomatic Society
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website